Svb Wealth LLC Alnylam Pharmaceuticals, Inc. Transaction History

Svb Wealth LLC

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Jul 24, 2023	BUY	$185.01 - $212.05 $4,995 - $5,725	27 Added 1.46%	1,872 $355,000
Q1 2023 May 12, 2023	SELL	$182.66 - $235.53 $37,262 - $48,048	-204 Reduced 9.96%	1,845 $369,000
Q4 2022 Feb 10, 2023	BUY	$185.53 - $241.31 $23,747 - $30,887	128 Added 6.66%	2,049 $486,000
Q3 2022 Nov 09, 2022	BUY	$138.54 - $232.0 $21,889 - $36,656	158 Added 8.96%	1,921 $384,000
Q2 2022 Aug 16, 2022	BUY	$120.42 - $169.29 $481 - $677	4 Added 0.23%	1,763 $257,000
Q1 2022 May 13, 2022	BUY	$127.18 - $173.91 $763 - $1,043	6 Added 0.34%	1,759 $287,000
Q4 2021 Feb 15, 2022	SELL	$159.56 - $209.29 $9,892 - $12,975	-62 Reduced 3.42%	1,753 $297,000
Q3 2021 Nov 09, 2021	BUY	$169.75 - $207.73 $8,657 - $10,594	51 Added 2.89%	1,815 $343,000
Q1 2021 May 11, 2021	SELL	$126.83 - $175.69 $225,630 - $312,552	-1,779 Closed	0 $0
Q3 2020 Nov 10, 2020	BUY	$121.19 - $165.49 $1,817 - $2,482	15 Added 0.85%	1,779 $259,000
Q2 2020 Aug 05, 2020	BUY	$104.21 - $156.44 $183,826 - $275,960	1,764 New	1,764 $261,000
Q1 2020 May 11, 2020	SELL	$93.12 - $133.99 $162,960 - $234,482	-1,750 Closed	0 $0
Q4 2019 Feb 13, 2020	BUY	$74.51 - $124.23 $130,392 - $217,402	1,750 New	1,750 $202,000
Q2 2018 Aug 14, 2018	SELL	$88.31 - $107.8 $154,542 - $188,650	-1,750 Closed	0 $0
Q1 2018 May 11, 2018	SELL	$115.92 - $148.54 $11,592 - $14,854	-100 Reduced 5.41%	1,750 $208,000
Q4 2017 Feb 13, 2018	SELL	$114.49 - $139.98 $29,194 - $35,694	-255 Reduced 12.11%	1,850 $235,000
Q3 2017 Nov 13, 2017	BUY	$72.53 - $118.27 $152,675 - $248,958	2,105	2,105 $247,000

642

109M

1.28M

1.21M

Ticker ALNY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 123,028,000
Market Cap $30.1B
Description
Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system...

Get notified when there are updates to the investment portfolio of Svb Wealth LLC, based on Form 13F filings with the SEC.

Stay updated on Svb Wealth LLC with notifications on news.